(Q30405205)

8 November 2017

Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10. (English)

1 reference

8 November 2017

0 references

0 references

Matthias an der Heiden

2

1 reference

8 November 2017

13

1 reference

8 November 2017

Daniel Faensen

10

0 references

Tim Eckmanns

14

object named as

Tim Eckmanns

1 reference

8 November 2017

9

Silke Buda

1 reference

8 November 2017

3

Brunhilde Schweiger

1 reference

8 November 2017

7

Martina Littmann

1 reference

8 November 2017

Helmut Uphoff

1

1 reference

8 November 2017

Hartmut Campe

4

1 reference

8 November 2017

Dietmar Beier

5

1 reference

8 November 2017

Carina Helmeke

6

1 reference

8 November 2017

Walter Haas

8

1 reference

8 November 2017

Marcel Feig

11

1 reference

8 November 2017

Doris Altmann

12

1 reference

8 November 2017

Udo Buchholz

15

1 reference

8 November 2017

language of work or name

English

0 references

publication date

18 July 2011

1 reference

8 November 2017

1 reference

8 November 2017

6

1 reference

8 November 2017

7

1 reference

8 November 2017

e19932

1 reference

Creative Commons Attribution 4.0 International

8 November 2017

start time

18 July 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

A novel influenza A (H1N1) vaccine in various age groups.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Efficacy and effectiveness of influenza vaccination

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Estimation of influenza vaccine effectiveness using routine surveillance data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Tutorial in biostatistics: the self-controlled case series method

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Traditional reviews, meta-analyses and pooled analyses in epidemiology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138735

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019932

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

21 January 2018

1 reference

12 December 2020

Cross-reaction but no avidity change of the serum antibody response after influenza vaccination

1 reference

12 December 2020

Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005

1 reference

12 December 2020

The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0019932

Identifiers

DOI

1 reference

8 November 2017

0 references

1 reference

8 November 2017

PubMed publication ID

21789163

1 reference